nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B3—Levothyroxine—hypothyroidism	0.138	0.156	CbGbCtD
Valsartan—SLCO1B3—Liothyronine—hypothyroidism	0.138	0.156	CbGbCtD
Valsartan—SLCO1B3—Liotrix—hypothyroidism	0.134	0.152	CbGbCtD
Valsartan—SLCO1B1—Dextrothyroxine—hypothyroidism	0.106	0.12	CbGbCtD
Valsartan—SLCO1B1—Liothyronine—hypothyroidism	0.0801	0.0906	CbGbCtD
Valsartan—SLCO1B1—Levothyroxine—hypothyroidism	0.0801	0.0906	CbGbCtD
Valsartan—SLCO1B1—Liotrix—hypothyroidism	0.0782	0.0885	CbGbCtD
Valsartan—ALB—Levothyroxine—hypothyroidism	0.0439	0.0496	CbGbCtD
Valsartan—ALB—Liothyronine—hypothyroidism	0.0439	0.0496	CbGbCtD
Valsartan—ALB—Liotrix—hypothyroidism	0.0428	0.0484	CbGbCtD
Valsartan—Serum sickness—Dextrothyroxine—hypothyroidism	0.00516	0.0601	CcSEcCtD
Valsartan—Serum sickness—Levothyroxine—hypothyroidism	0.00516	0.0601	CcSEcCtD
Valsartan—Serum sickness—Liotrix—hypothyroidism	0.0038	0.0442	CcSEcCtD
Valsartan—CYP2C9—urine—hypothyroidism	0.00227	0.113	CbGeAlD
Valsartan—Cardiac failure—Levothyroxine—hypothyroidism	0.0018	0.021	CcSEcCtD
Valsartan—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0018	0.021	CcSEcCtD
Valsartan—Blood urea increased—Liotrix—hypothyroidism	0.00168	0.0196	CcSEcCtD
Valsartan—SLCO1B3—pituitary gland—hypothyroidism	0.00167	0.0831	CbGeAlD
Valsartan—Hypotension—Liothyronine—hypothyroidism	0.00164	0.0191	CcSEcCtD
Valsartan—Muscular weakness—Levothyroxine—hypothyroidism	0.00155	0.018	CcSEcCtD
Valsartan—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00155	0.018	CcSEcCtD
Valsartan—Swelling—Liotrix—hypothyroidism	0.00147	0.0171	CcSEcCtD
Valsartan—Renal failure acute—Liotrix—hypothyroidism	0.0014	0.0163	CcSEcCtD
Valsartan—Renal impairment—Liotrix—hypothyroidism	0.00136	0.0158	CcSEcCtD
Valsartan—Cardiac failure—Liotrix—hypothyroidism	0.00132	0.0154	CcSEcCtD
Valsartan—AGTR1—adrenal cortex—hypothyroidism	0.00125	0.0624	CbGeAlD
Valsartan—Blood creatinine increased—Liotrix—hypothyroidism	0.00121	0.0141	CcSEcCtD
Valsartan—AGTR1—heart—hypothyroidism	0.00121	0.0604	CbGeAlD
Valsartan—SLCO1B3—liver—hypothyroidism	0.00116	0.0581	CbGeAlD
Valsartan—AGTR1—cardiovascular system—hypothyroidism	0.00114	0.057	CbGeAlD
Valsartan—Muscular weakness—Liotrix—hypothyroidism	0.00114	0.0133	CcSEcCtD
Valsartan—Bronchitis—Liotrix—hypothyroidism	0.00107	0.0125	CcSEcCtD
Valsartan—Alopecia—Levothyroxine—hypothyroidism	0.00107	0.0125	CcSEcCtD
Valsartan—Alopecia—Dextrothyroxine—hypothyroidism	0.00107	0.0125	CcSEcCtD
Valsartan—AGTR1—pituitary gland—hypothyroidism	0.00101	0.0504	CbGeAlD
Valsartan—Renal failure—Liotrix—hypothyroidism	0.000979	0.0114	CcSEcCtD
Valsartan—Angioedema—Levothyroxine—hypothyroidism	0.000967	0.0113	CcSEcCtD
Valsartan—Angioedema—Dextrothyroxine—hypothyroidism	0.000967	0.0113	CcSEcCtD
Valsartan—Palpitations—Levothyroxine—hypothyroidism	0.000935	0.0109	CcSEcCtD
Valsartan—Palpitations—Dextrothyroxine—hypothyroidism	0.000935	0.0109	CcSEcCtD
Valsartan—ALB—heart—hypothyroidism	0.000933	0.0466	CbGeAlD
Valsartan—AGTR1—adrenal gland—hypothyroidism	0.000903	0.0451	CbGeAlD
Valsartan—AGTR1—blood—hypothyroidism	0.000903	0.045	CbGeAlD
Valsartan—Arthralgia—Dextrothyroxine—hypothyroidism	0.000901	0.0105	CcSEcCtD
Valsartan—Arthralgia—Levothyroxine—hypothyroidism	0.000901	0.0105	CcSEcCtD
Valsartan—Anxiety—Dextrothyroxine—hypothyroidism	0.000898	0.0105	CcSEcCtD
Valsartan—Anxiety—Levothyroxine—hypothyroidism	0.000898	0.0105	CcSEcCtD
Valsartan—SLCO1B3—Transport of organic anions—AVP—hypothyroidism	0.000879	0.0842	CbGpPWpGaD
Valsartan—AGTR1—thyroid gland—hypothyroidism	0.000871	0.0435	CbGeAlD
Valsartan—SLCO1B1—blood—hypothyroidism	0.000861	0.043	CbGeAlD
Valsartan—Shock—Dextrothyroxine—hypothyroidism	0.00085	0.00989	CcSEcCtD
Valsartan—Shock—Levothyroxine—hypothyroidism	0.00085	0.00989	CcSEcCtD
Valsartan—Alopecia—Liotrix—hypothyroidism	0.00079	0.0092	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000787	0.00916	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000787	0.00916	CcSEcCtD
Valsartan—Insomnia—Levothyroxine—hypothyroidism	0.000781	0.0091	CcSEcCtD
Valsartan—Insomnia—Dextrothyroxine—hypothyroidism	0.000781	0.0091	CcSEcCtD
Valsartan—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00077	0.00897	CcSEcCtD
Valsartan—Dyspnoea—Levothyroxine—hypothyroidism	0.00077	0.00897	CcSEcCtD
Valsartan—Flatulence—Liotrix—hypothyroidism	0.000767	0.00893	CcSEcCtD
Valsartan—Dysgeusia—Liotrix—hypothyroidism	0.000762	0.00888	CcSEcCtD
Valsartan—AGTR1—testis—hypothyroidism	0.000747	0.0373	CbGeAlD
Valsartan—Fatigue—Levothyroxine—hypothyroidism	0.000745	0.00867	CcSEcCtD
Valsartan—Fatigue—Dextrothyroxine—hypothyroidism	0.000745	0.00867	CcSEcCtD
Valsartan—Vision blurred—Liotrix—hypothyroidism	0.000734	0.00854	CcSEcCtD
Valsartan—Angioedema—Liotrix—hypothyroidism	0.000711	0.00828	CcSEcCtD
Valsartan—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000706	0.00822	CcSEcCtD
Valsartan—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000706	0.00822	CcSEcCtD
Valsartan—AGTR1—liver—hypothyroidism	0.000706	0.0352	CbGeAlD
Valsartan—Syncope—Liotrix—hypothyroidism	0.000698	0.00813	CcSEcCtD
Valsartan—ALB—adrenal gland—hypothyroidism	0.000697	0.0348	CbGeAlD
Valsartan—AGTR1—Arf6 trafficking events—CLTC—hypothyroidism	0.000694	0.0665	CbGpPWpGaD
Valsartan—Palpitations—Liotrix—hypothyroidism	0.000688	0.00801	CcSEcCtD
Valsartan—Urticaria—Levothyroxine—hypothyroidism	0.000686	0.00799	CcSEcCtD
Valsartan—Urticaria—Dextrothyroxine—hypothyroidism	0.000686	0.00799	CcSEcCtD
Valsartan—Loss of consciousness—Liotrix—hypothyroidism	0.000684	0.00797	CcSEcCtD
Valsartan—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000683	0.00795	CcSEcCtD
Valsartan—Abdominal pain—Levothyroxine—hypothyroidism	0.000683	0.00795	CcSEcCtD
Valsartan—AGTR1—Arf6 signaling events—TSHR—hypothyroidism	0.000677	0.0649	CbGpPWpGaD
Valsartan—SLCO1B1—liver—hypothyroidism	0.000673	0.0336	CbGeAlD
Valsartan—Arthralgia—Liotrix—hypothyroidism	0.000663	0.00772	CcSEcCtD
Valsartan—Chest pain—Liotrix—hypothyroidism	0.000663	0.00772	CcSEcCtD
Valsartan—Anxiety—Liotrix—hypothyroidism	0.00066	0.00769	CcSEcCtD
Valsartan—Oedema—Liotrix—hypothyroidism	0.000635	0.0074	CcSEcCtD
Valsartan—Anaphylactic shock—Liotrix—hypothyroidism	0.000635	0.0074	CcSEcCtD
Valsartan—Infection—Liotrix—hypothyroidism	0.000631	0.00735	CcSEcCtD
Valsartan—Shock—Liotrix—hypothyroidism	0.000625	0.00728	CcSEcCtD
Valsartan—Asthenia—Dextrothyroxine—hypothyroidism	0.00062	0.00721	CcSEcCtD
Valsartan—Asthenia—Levothyroxine—hypothyroidism	0.00062	0.00721	CcSEcCtD
Valsartan—Pruritus—Levothyroxine—hypothyroidism	0.000611	0.00711	CcSEcCtD
Valsartan—Pruritus—Dextrothyroxine—hypothyroidism	0.000611	0.00711	CcSEcCtD
Valsartan—Anorexia—Liotrix—hypothyroidism	0.000606	0.00705	CcSEcCtD
Valsartan—Hypotension—Liotrix—hypothyroidism	0.000594	0.00691	CcSEcCtD
Valsartan—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000591	0.00688	CcSEcCtD
Valsartan—Diarrhoea—Levothyroxine—hypothyroidism	0.000591	0.00688	CcSEcCtD
Valsartan—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.00059	0.0566	CbGpPWpGaD
Valsartan—CYP2C9—heart—hypothyroidism	0.000583	0.0291	CbGeAlD
Valsartan—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000579	0.00674	CcSEcCtD
Valsartan—ALB—testis—hypothyroidism	0.000576	0.0287	CbGeAlD
Valsartan—Insomnia—Liotrix—hypothyroidism	0.000575	0.00669	CcSEcCtD
Valsartan—Paraesthesia—Liotrix—hypothyroidism	0.000571	0.00664	CcSEcCtD
Valsartan—Dyspnoea—Liotrix—hypothyroidism	0.000566	0.00659	CcSEcCtD
Valsartan—Decreased appetite—Liotrix—hypothyroidism	0.000552	0.00643	CcSEcCtD
Valsartan—CYP2C9—cardiovascular system—hypothyroidism	0.00055	0.0274	CbGeAlD
Valsartan—Vomiting—Dextrothyroxine—hypothyroidism	0.000549	0.00639	CcSEcCtD
Valsartan—Vomiting—Levothyroxine—hypothyroidism	0.000549	0.00639	CcSEcCtD
Valsartan—Fatigue—Liotrix—hypothyroidism	0.000548	0.00638	CcSEcCtD
Valsartan—Rash—Levothyroxine—hypothyroidism	0.000545	0.00634	CcSEcCtD
Valsartan—Rash—Dextrothyroxine—hypothyroidism	0.000545	0.00634	CcSEcCtD
Valsartan—ALB—liver—hypothyroidism	0.000545	0.0272	CbGeAlD
Valsartan—Dermatitis—Levothyroxine—hypothyroidism	0.000544	0.00633	CcSEcCtD
Valsartan—Dermatitis—Dextrothyroxine—hypothyroidism	0.000544	0.00633	CcSEcCtD
Valsartan—Constipation—Liotrix—hypothyroidism	0.000543	0.00633	CcSEcCtD
Valsartan—Headache—Dextrothyroxine—hypothyroidism	0.000541	0.0063	CcSEcCtD
Valsartan—Headache—Levothyroxine—hypothyroidism	0.000541	0.0063	CcSEcCtD
Valsartan—AGTR1—Arf6 trafficking events—TSHR—hypothyroidism	0.000535	0.0513	CbGpPWpGaD
Valsartan—Gastrointestinal pain—Liotrix—hypothyroidism	0.00052	0.00605	CcSEcCtD
Valsartan—Nausea—Levothyroxine—hypothyroidism	0.000513	0.00597	CcSEcCtD
Valsartan—Nausea—Dextrothyroxine—hypothyroidism	0.000513	0.00597	CcSEcCtD
Valsartan—Urticaria—Liotrix—hypothyroidism	0.000505	0.00588	CcSEcCtD
Valsartan—Abdominal pain—Liotrix—hypothyroidism	0.000502	0.00585	CcSEcCtD
Valsartan—Hypersensitivity—Liotrix—hypothyroidism	0.000468	0.00545	CcSEcCtD
Valsartan—Asthenia—Liotrix—hypothyroidism	0.000456	0.00531	CcSEcCtD
Valsartan—Pruritus—Liotrix—hypothyroidism	0.00045	0.00523	CcSEcCtD
Valsartan—CYP2C9—blood—hypothyroidism	0.000435	0.0217	CbGeAlD
Valsartan—Diarrhoea—Liotrix—hypothyroidism	0.000435	0.00506	CcSEcCtD
Valsartan—Dizziness—Liotrix—hypothyroidism	0.00042	0.00489	CcSEcCtD
Valsartan—Vomiting—Liotrix—hypothyroidism	0.000404	0.0047	CcSEcCtD
Valsartan—Rash—Liotrix—hypothyroidism	0.000401	0.00466	CcSEcCtD
Valsartan—Dermatitis—Liotrix—hypothyroidism	0.0004	0.00466	CcSEcCtD
Valsartan—Headache—Liotrix—hypothyroidism	0.000398	0.00463	CcSEcCtD
Valsartan—Nausea—Liotrix—hypothyroidism	0.000377	0.00439	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—TSHR—hypothyroidism	0.000372	0.0357	CbGpPWpGaD
Valsartan—CYP2C9—liver—hypothyroidism	0.00034	0.017	CbGeAlD
Valsartan—ALB—Transport of organic anions—AVP—hypothyroidism	0.000337	0.0323	CbGpPWpGaD
Valsartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000326	0.0312	CbGpPWpGaD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000293	0.0281	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000222	0.0213	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000219	0.021	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—TRH—hypothyroidism	0.000199	0.0191	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000196	0.0188	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000184	0.0177	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000178	0.017	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000149	0.0143	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000132	0.0126	CbGpPWpGaD
Valsartan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000125	0.012	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000124	0.0119	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000117	0.0112	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000117	0.0112	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000113	0.0108	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—AVP—hypothyroidism	0.000104	0.01	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000103	0.00988	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—TRH—hypothyroidism	0.0001	0.00961	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.36e-05	0.00898	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	9.34e-05	0.00895	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—TSHB—hypothyroidism	8.93e-05	0.00856	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—TSHR—hypothyroidism	8.93e-05	0.00856	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.89e-05	0.00852	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	8.54e-05	0.00818	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—IYD—hypothyroidism	7.64e-05	0.00732	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.59e-05	0.00728	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	7.07e-05	0.00678	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	7e-05	0.00671	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.91e-05	0.00663	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—POMC—hypothyroidism	6.85e-05	0.00657	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ATP5O—hypothyroidism	6.49e-05	0.00622	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.29e-05	0.00603	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TPO—hypothyroidism	6.1e-05	0.00585	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.97e-05	0.00573	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—TRH—hypothyroidism	5.66e-05	0.00543	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.66e-05	0.00542	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—AVP—hypothyroidism	5.27e-05	0.00505	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TRH—hypothyroidism	5.14e-05	0.00493	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—IYD—hypothyroidism	5.13e-05	0.00492	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—TSHB—hypothyroidism	5.05e-05	0.00484	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—TSHR—hypothyroidism	5.05e-05	0.00484	CbGpPWpGaD
Valsartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.72e-05	0.00453	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.7e-05	0.00451	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.59e-05	0.00441	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TSHR—hypothyroidism	4.58e-05	0.0044	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TSHB—hypothyroidism	4.58e-05	0.0044	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.52e-05	0.00433	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—IGF1—hypothyroidism	4.41e-05	0.00423	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ATP5O—hypothyroidism	4.36e-05	0.00418	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	4.34e-05	0.00416	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	4.2e-05	0.00403	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TPO—hypothyroidism	4.1e-05	0.00393	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.83e-05	0.00367	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.8e-05	0.00364	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	3.59e-05	0.00345	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	3.56e-05	0.00341	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CLTC—hypothyroidism	3.52e-05	0.00337	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—POMC—hypothyroidism	3.5e-05	0.00335	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	3.41e-05	0.00327	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	3.18e-05	0.00304	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—VAV3—hypothyroidism	3.09e-05	0.00296	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TRH—hypothyroidism	3.04e-05	0.00291	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.04e-05	0.00291	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AVP—hypothyroidism	2.98e-05	0.00285	CbGpPWpGaD
Valsartan—ALB—Metabolism—IYD—hypothyroidism	2.93e-05	0.00281	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TSHB—hypothyroidism	2.83e-05	0.00271	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—VAV3—hypothyroidism	2.8e-05	0.00269	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TSHB—hypothyroidism	2.71e-05	0.0026	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TSHR—hypothyroidism	2.71e-05	0.0026	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AVP—hypothyroidism	2.7e-05	0.00259	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	2.69e-05	0.00258	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	2.52e-05	0.00241	CbGpPWpGaD
Valsartan—ALB—Metabolism—ATP5O—hypothyroidism	2.49e-05	0.00239	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.49e-05	0.00238	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SH2B3—hypothyroidism	2.41e-05	0.00231	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—IYD—hypothyroidism	2.4e-05	0.0023	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.39e-05	0.00229	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SH2B3—hypothyroidism	2.39e-05	0.00229	CbGpPWpGaD
Valsartan—ALB—Metabolism—TPO—hypothyroidism	2.34e-05	0.00225	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.17e-05	0.00208	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	2.12e-05	0.00203	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ATP5O—hypothyroidism	2.04e-05	0.00196	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—hypothyroidism	2.03e-05	0.00195	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—hypothyroidism	1.98e-05	0.0019	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.96e-05	0.00187	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TPO—hypothyroidism	1.92e-05	0.00184	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.9e-05	0.00182	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—hypothyroidism	1.8e-05	0.00172	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRL—hypothyroidism	1.79e-05	0.00172	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.78e-05	0.0017	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.73e-05	0.00166	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.69e-05	0.00162	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.67e-05	0.0016	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VAV3—hypothyroidism	1.66e-05	0.00159	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VAV3—hypothyroidism	1.64e-05	0.00157	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AVP—hypothyroidism	1.6e-05	0.00153	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.42e-05	0.00136	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	1.37e-05	0.00131	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—hypothyroidism	1.11e-05	0.00106	CbGpPWpGaD
Valsartan—ALB—Metabolism—TSHB—hypothyroidism	1.08e-05	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—hypothyroidism	1.06e-05	0.00102	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1—hypothyroidism	1.02e-05	0.000978	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF1—hypothyroidism	1.01e-05	0.000966	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIK3C2A—hypothyroidism	9.67e-06	0.000927	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	9.54e-06	0.000915	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TSHB—hypothyroidism	8.88e-06	0.000851	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC5A5—hypothyroidism	8.12e-06	0.000779	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	7.92e-06	0.000759	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.81e-06	0.000749	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—hypothyroidism	7.44e-06	0.000713	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC5A5—hypothyroidism	6.65e-06	0.000637	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—hypothyroidism	4.25e-06	0.000407	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—hypothyroidism	3.48e-06	0.000333	CbGpPWpGaD
